Inhibition of HIV-1 replication by antisense RNA expression
US6776986B1 · kind B1 · utility
2Cited by
12References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 23, 1998 |
| Grant date | Aug 17, 2004 |
| Priority date | — |
| Expiry date | Nov 23, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16322
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel antisense sequences to the unspliced or single spliced portions of mRNA transcript from HIV-1 provirus, optionally co-expressed with an inhibitory transdominant mutant HIV-1 protein, are found to be useful in the treatment of HIV-1 infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.